Terms: = Lymphoma AND FAM46C, Q5VWP2, FLJ20202, ENSG00000183508, 54855
3 results:
1. Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.
Quivoron C; Michot JM; Danu A; Lecourt H; Saada V; Saleh K; Vergé V; Cotteret S; Bernard OA; Ribrag V
Leuk Lymphoma; 2024 Jun; 65(6):789-799. PubMed ID: 38433500
[TBL] [Abstract] [Full Text] [Related]
2. fam46c-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
[TBL] [Abstract] [Full Text] [Related]
3. Microhomology-mediated end joining drives complex rearrangements and overexpression of
Mikulasova A; Ashby C; Tytarenko RG; Qu P; Rosenthal A; Dent JA; Ryan KR; Bauer MA; Wardell CP; Hoering A; Mavrommatis K; Trotter M; Deshpande S; Yaccoby S; Tian E; Keats J; Auclair D; Jackson GH; Davies FE; Thakurta A; Morgan GJ; Walker BA
Haematologica; 2020 Apr; 105(4):1055-1066. PubMed ID: 31221783
[No Abstract] [Full Text] [Related]